Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Sandoz Glimepiride (2014-01-24)

Starting date:
January 27, 2014
Posting date:
January 28, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-37751

Recalled products

A. Sandoz Glimepiride, 1 milligram (mg)

B. Sandoz Glimepiride, 2 mg

Reason

Recall initiated following the discovery of blisters of Sandoz Glimepiride 2 mg tablets, Lot DM5336, erroneously packaged in a box identified Sandoz Glimepiride 1 mg.  Therefore, units of this lot could be found in 1 mg or 2 mg inventories.

Depth of distribution

Wholesalers and pharmacies in Canada

Affected products

A. Sandoz Glimepiride, 1 mg

DIN, NPN, DIN-HIM
DIN 02269589
Dosage form

Tablet

Strength

1 mg

Lot or serial number

DM5336

Companies
Recalling Firm
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA

B. Sandoz Glimepiride, 2 mg

DIN, NPN, DIN-HIM
DIN 02269597
Dosage form

Tablet

Strength

2 mg

Lot or serial number

DM5336

Companies
Recalling Firm
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA